Over the last couple of decades, livestock health has been gaining popularity as a result of growing awareness backed by compelling scientific evidence linking animal health with human food safety and public health.
In other words, the health of animals, especially in the food animal production system, has a far-reaching impact on the food chain. With consumers demanding risk-free food and with governments across the world focused on building newer systems for superior animal health management, the opportunities for animal health products, including animal health is on the rise. The current unmet, latent, and evolving animal health care needs are expected to drive the growth of the animal health market in the coming years.
Download PDF Brochure Of This Report - http://www.micromarketmonitor.com/contact/8391849893-download_pdf_brochure.html
This report provides a competitive landscape of the top players. Under the strategic benchmarking section, we will provide you with their key developments along with the impacts that include new product developments, M&A, a strategic focus on any specific application, technology, and geography. Under the Financials section, we will provide you with details that span Capex (Investments), revenues, EBITDA, etc. Under the operational insights section, we will provide you with the new capacities added, new centers, and new key employments. Under the sales and marketing section, we will provide you with insights on new contracts (available on the public domain), new distribution channels added, new marketing initiatives, and so on.
-Audience for this report
Global animal health companies
The major players in the global animal medication market include Abbott Animal Health, Bayer HealthCare AG, Boehringer Ingelheim GmbH, Ceva Santé Animale S.A., Dechra Pharmaceuticals PLC, Eli Lilly and Company, Merck Animal Health, Merial Limited, Novartis Animal Health, Inc., Pfizer, Inc., Vetericyn, Inc., Vétoquinol SA, and Virbac SA.